期刊文献+

2型糖尿病肾病患者疾病相关危险因素分析 被引量:4

Analysis of related risk factors of Type-2 Diabetes Nephropathy
下载PDF
导出
摘要 目的分析2型糖尿病肾病(T2DN)患者疾病相关危险因素,探讨其与T2DN发生、发展的相关性。方法将300例T2DM患者根据尿白蛋白排泄率(UAER)不同分为三组,即A组101例、B组105例和C组94例。观察各组间相关指标的变化情况,分析与疾病的相关性。结果三组患者在性别、年龄、体重指数(BMI)、空腹血糖(FBG)、餐后2 h血糖(2 h PG)方面比较差异均无统计学意义(P>0.05);B组与C组患者病程长于A组(P<0.05),Hb A1c高于A组(P<0.05);B组患者尿素氮(BUN)、SCr、尿酸(UA)和UMA指标均高于A组(P<0.05);C组患者BUN、SCr、UA和UMA指标均高于A组和B组(P<0.05)。Logistic回归分析显示,病程、Hb A1c、SCr、UA和UAER是T2DN的相关危险因素。结论病程、Hb A1c、SCr、UA与T2DN的发生、发展有密切关系,病程、Hb A1c、SCr、UA与UAER呈正相关性。 Objective To investigate the related risk factors of Type-2 Diabetes Nephropathy( T2DN). Methods Three hundred T2 DN patients were divided into three groups; group A( n = 101),group B( n = 105) and group C( n = 94) according to UAER of the patients and relevant index change was observed and relevant factors of the disease were analyzed. Results There was no difference of statistical significance in the gender,age,BMI,FBG and 2h PBG among the three groups( P〉0. 05),the courses of disease of group B and C were longer than that of group A( P〈0. 05),Hb A1 c was higher than that of group A( P〈0. 05),and BUN,SCr,UA and UMA of group C were higher than that of group A and B( P〈0. 05). As shown by non-conditional Logistic regression analysis,the course of disease,Hb A1 c,SCr,UA and UAER were the relevant risk factors of T2 DN. Conclusion The course of disease,Hb A1 c,SCr,and UA are closely related to the occurrence and development of T2 DN,and the course of disease,Hb A1 c,SCr,and UA are positively correlated with UAER.
作者 董建新 林坚
出处 《白求恩医学杂志》 2015年第1期24-25,共2页 Journal of Bethune Medical Science
关键词 2型糖尿病肾病 糖化血红蛋白 尿微量白蛋白 肌酐 Type-2 Diabetes Nephropathy(T2DN) Glycosylated hemoglobin Urinary microalbuminuria Creatinine
  • 相关文献

参考文献4

二级参考文献35

  • 1沈琴,贾伟平,包玉倩,陆俊茜,陆惠娟,左玉华,杜颉,刘兰花,方蓉.社区糖尿病及糖调节受损人群周围血管病变的患病率调查[J].中华医学杂志,2006,86(22):1530-1533. 被引量:41
  • 2管珩,刘志民,李光伟,郭晓蕙,许樟榕,邹大进,邢惠莉,刘伟,盛正妍,田浩明,朱大龙,于德民,庄维特,陈璐璐,翁建平.50岁以上糖尿病人群周围动脉闭塞性疾病相关因素分析[J].中华医学杂志,2007,87(1):23-27. 被引量:119
  • 3Norgren L, Hiatt WR, Dormandy JA, et al. TASC II Working Group. inter-society consensus for the management of peripheral arterial disease(TASC II). J Vasc Surgery, 2007,33: S1-S75.
  • 4Guerrero A, Montes R, Munoz-Terol J, et al. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant, 2006,21:3525-3531.
  • 5O'Hare A,Glidden DV,Fox CS, et al. High prevalence oI peripheral arterial disease in persons with renal insufficiency. Circulation, 2004,109 : 320-323.
  • 6Mostaza J, Suarez C, Manzano L, et al. Relationship between ankle-brachial index and chronic kidney disease in hypertensive patients with no Known cardiovascular disease. J Am Soc Nephrol, 2006,17: S201-S205.
  • 7Chen JH, Chen SC, Liu WC, et al. Determinants of peripheral arterial stiffness in patients with chronic kidney disease in southern Taiwan. Kaohsiung J IVied Sci , 2009,25: 366-373.
  • 8Deloach S, Mohler E. Peripheral Arterial Disease: A Guide for Nephrologists. Clin J Am Soc Nephrol , 2007, 2: 839-846.
  • 9Adler Al, Stevens RJ, Manley SE,et al. Development andprogression of nephropathy in type 2 diabetes : the UnitedKingdom Prospective Diabetes Study (UKPDS 64)[J], KidneyInt,2003,63( 1):225-232.
  • 10National Institutes of Health and National Institute of Dia-betes and Digestive and Kidney Diseases. USRDS 2009 An-nuacroanl Data Report : Atlas of Chronic Kidney Disease andEnd-Stage Renal Disease in the United States. Bethesda,MD : National Institutes of Health,2009.

共引文献123

同被引文献41

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部